SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-24-006131
Filing Date
2024-02-07
Accepted
2024-02-07 16:05:27
Documents
2
Group Members
EXODUSPOINT CAPITAL PARTNERS GP, LLCHYUNG LEEMICHAEL GELBAND

Document Format Files

Seq Description Document Type Size
1 SC 13G/A ef20020858_sc13ga.htm SC 13G/A 122653
2 EXHIBIT 99.1 ef20020858_ex99-1.htm EX-99.1 8483
  Complete submission text file 0001140361-24-006131.txt   132961
Mailing Address 65 E 55TH STREET 9TH FLOOR NEW YORK NY 10022
Business Address 65 E 55TH STREET 9TH FLOOR NEW YORK NY 10022 6469409426
ExodusPoint Capital Management, LP (Filed by) CIK: 0001736225 (see all company filings)

IRS No.: 371875900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Subject) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92657 | Film No.: 24604281
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)